Want to see IN:INDGN full AI Analyst Report?
INDGN Stock Chart & Stats
₹492.75
₹15.40(3.13%)
At close: 4:00 PM EDT
₹492.75
₹15.40(3.13%)
Day’s Range― - ―
52-Week Range₹414.90 - ₹596.50
Previous CloseN/A
Volume165.17K
Average Volume (3M)17.62K
Market Cap
₹136.87B
Enterprise Value₹91.58K
Total Cash (Recent Filing)₹14.81B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)34.0
Beta0.51
Next Earnings
Nov 04, 2026EPS Estimate
5.2Next Dividend Ex-DateN/A
Dividend Yield0.4%
Share Statistics
EPS (TTM)16.70
Shares Outstanding240,954,300
10 Day Avg. Volume12,460
30 Day Avg. Volume17,622
Financial Highlights & Ratios
PEG Ratio-10.37
Price to Book (P/B)3.32
Price to Sales (P/S)2.97
P/FCF Ratio16.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)23.92
Revenue Forecast (FY)₹44.36B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line growth, including ~15% in 2026, indicates durable demand for Indegene's commercialization and medical services. Persistent revenue expansion supports scale, deeper client engagement and continued reinvestment in capabilities that underpin long-term competitiveness.
Conservative Balance SheetVery low leverage and a growing equity base provide financial flexibility to fund organic growth, pursue strategic investments, and absorb shocks. A conservative balance sheet reduces refinancing risk and supports durable capital allocation decisions over a multi-quarter horizon.
Strong Recent Free Cash FlowRobust free cash flow across 2024–2026 demonstrates the company's ability to convert earnings into cash when conditions are favorable. Reliable cash generation supports reinvestment in services, technology, and client programs, enhancing long-term operational resilience.
Bears Say
Volatile Cash-flow ConversionMaterial swings in operating cash flow and intermittent negative free cash flow years signal uneven cash conversion and earnings quality. This volatility complicates multi-quarter planning, increases reliance on working capital management, and raises execution risk for sustained investment.
Inconsistent Margin DataInconsistencies and unusually high reported gross margins reduce confidence in assessing sustainable operating efficiency. That weakens ability to model long-term profitability, obscures true margin drivers, and increases risk that reported margins may not persist under scaling or adverse conditions.
Rising Debt In 2026An upward move in total debt after a period of very low leverage signals a potential shift in financing mix. If the trend continues, it could reduce flexibility and raise interest or covenant risks, especially if cash-flow volatility or margin pressure coincides with higher leverage.
Indegene Limited News
INDGN FAQ
What was Indegene Limited’s price range in the past 12 months?
Indegene Limited lowest stock price was ₹414.90 and its highest was ₹596.50 in the past 12 months.
What is Indegene Limited’s market cap?
Indegene Limited’s market cap is ₹136.87B.
When is Indegene Limited’s upcoming earnings report date?
Indegene Limited’s upcoming earnings report date is Nov 04, 2026 which is in 73 days.
How were Indegene Limited’s earnings last quarter?
Indegene Limited released its earnings results on Jul 30, 2026. The company reported ₹4.8 earnings per share for the quarter, beating the consensus estimate of ₹4.633 by ₹0.167.
Is Indegene Limited overvalued?
According to Wall Street analysts Indegene Limited’s price is currently Overvalued.
Does Indegene Limited pay dividends?
Indegene Limited pays a Annually dividend of ₹2.25 which represents an annual dividend yield of 0.4%. See more information on Indegene Limited dividends here
What is Indegene Limited’s EPS estimate?
Indegene Limited’s EPS estimate is 5.2.
How many shares outstanding does Indegene Limited have?
Indegene Limited has 240,954,300 shares outstanding.
What happened to Indegene Limited’s price movement after its last earnings report?
Indegene Limited reported an EPS of ₹4.8 in its last earnings report, beating expectations of ₹4.633. Following the earnings report the stock price went down -1.747%.
Which hedge fund is a major shareholder of Indegene Limited?
Currently, no hedge funds are holding shares in IN:INDGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Indegene Limited
Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.
Technical Analysis
Birlasoft Limited
―
Cyient Limited
―
Latent View Analytics Limited
―
Tanla Platforms Ltd
―
Zensar Technologies Limited
―